Economic Evaluation Of Alternative Pneumococcal Vaccination Strategies
Funder
National Health and Medical Research Council
Funding Amount
$242,894.00
Summary
Pneumococcal vaccination is a readily available preventive strategy that can offer substantial protection to the elderly but it is important that we carefully evaluate the different potential strategies to ensure the most (cost-) effective approach to prevention is identified. This grant will explore alternative strategies to control pneumococcal-related disease in elderly Australians using the available vaccines.
Developing An Australian Valuation For The EQ-5D-5L Quality Of Life Instrument
Funder
National Health and Medical Research Council
Funding Amount
$348,357.00
Summary
In the assessment of gains resulting from a health technology, it is standard to consider both mortality and quality of life effects. This project explores how Australians value different components of quality of life. To do this, we are running an online survey called a discrete choice experiment, and analysing the data using a range of cutting-edge econometric techniques. This will allow policy-makers to better reflect people's preferences when making decisions about new technologies.
The Value Of Providing Health Interventions For Heroin Use: A Cost Benefit Analysis
Funder
National Health and Medical Research Council
Funding Amount
$599,585.00
Summary
Heroin use and associated harms can be reduced through effective treatment. Past research has shown that treatment for heroin dependence can be relatively cost-effective, but not whether heroin treatment overall is a good investment. This unique study will estimate the net social benefit of heroin treatment, taking into account health, crime and family consequences. The results will help Australia respond better to this devastating health problem.
Social And Decision Maker Preferences For Priority Setting In Health Care Resource Allocation
Funder
National Health and Medical Research Council
Funding Amount
$273,051.00
Summary
All countries face the question of how best to allocate scarce health care resources. This leads to questions such as do we value health gains to different people (e.g. young versus old) differently, or different types of health gain (improved quality of life or life extension) differently? Survey methods will be used to investigate how members of society and “decision makers” prioritise different types of health gain. Results will help Australia to make informed resource allocation decisions.
Increasing Population Health By Making Better Funding Decisions: Estimation Of The Cost-effectiveness Threshold For The Australian Health System
Funder
National Health and Medical Research Council
Funding Amount
$341,368.00
Summary
This project will estimate the Australian opportunity cost of decisions to fund new health care technologies, such as pharmaceuticals and medical devices. The opportunity cost represents the health benefits that could be achieved if the resources used to fund a new technology are used to fund the best alternative technology or service instead. We will then disseminate the information to decision makers, to improve funding decisions, and hence the efficiency of the Australian health care system.
Development And Valuation Of Cancer-specific Multi-attribute Health States For Use In Economic Evaluation
Funder
National Health and Medical Research Council
Funding Amount
$707,671.00
Summary
Economic evaluation is used by the Australian government in deciding which medical services and pharmaceuticals should be funded. This study will develop quality of life utility measures for use in economic evaluation of cancer interventions in Australia and internationally. This represents a significant methodological contribution to the assessment of quality of life, effectiveness and efficiency in cancer, in one of Australia's national health priority areas.